Disposition of 7400 shares by Bruce Rogers of Morphic Holding at 4.3151 subject to Rule 16b-3
Roughly 67% of Morphic Holding's investor base is looking to short. The analysis of current outlook of investing in Morphic Holding suggests that many traders are alarmed regarding Morphic Holding's prospects. The current market sentiment, together with Morphic Holding's historical and current headlines, can help investors time the market. In addition, many technical investors use Morphic Holding stock news signals to limit their universe of possible portfolio assets.
Morphic |
Filed transaction by Morphic Holding Officer: President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Morphic Holding Fundamental Analysis
We analyze Morphic Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Morphic Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Morphic Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Morphic Holding is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Morphic Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Morphic Holding stock to make a market-neutral strategy. Peer analysis of Morphic Holding could also be used in its relative valuation, which is a method of valuing Morphic Holding by comparing valuation metrics with similar companies.
Peers
Morphic Holding Related Equities
VTYX | Ventyx Biosciences | 16.36 | ||||
INZY | Inozyme Pharma | 7.72 | ||||
VKTX | Viking Therapeutics | 4.30 | ||||
STOK | Stoke Therapeutics | 1.95 | ||||
MDGL | Madrigal Pharmaceuticals | 1.88 | ||||
PLRX | Pliant Therapeutics | 1.88 | ||||
PCVX | Vaxcyte | 1.87 | ||||
PTGX | Protagonist Therapeutics | 1.51 | ||||
TERN | Terns Pharmaceuticals | 1.41 | ||||
AKRO | Akero Therapeutics | 0.57 | ||||
ACLX | Arcellx | 0.48 | ||||
RVMD | Revolution Medicines | 0.27 | ||||
IMCR | Immunocore Holdings | 0.13 | ||||
ETNB | 89bio | 0.25 | ||||
RNA | Avidity Biosciences | 2.18 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Morphic Stock
If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |